Clinical Trial Update: Cryopreserved MMUD BM With PTCy for Hematologic Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial of cryopreserved MMUD bone marrow with post-transplant cyclophosphamide for hematologic malignancies has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Biphenotypic Acute Leukemia
• Leukemia
• Myelodysplastic Syndromes
• T-lymphoblastic Lymphoma
• Undifferentiated Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Ossium Health, Inc. | Conditions: Acute Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: WITHDRAWN